Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

919

currently held

Exits tracked

338

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Save searches, build watchlists, pick up where you left off. Free, no credit card.

Start free

1,150 companies matching · Page 21 of 23

Company	Sector	Geo	Investor	Entry	Status
Lakepharma Summit Partners Growth Equity Fund X	Biotech	USA	Summit Partners	–	Active
LAmAb Biologics, Inc. TVM Life Science Innovation	Biotech	United States	TVM Capital Life Science	2023	Active
Lead Biologics Almi Invest (Regional funds)	Biotech	Sweden	Almi Invest	2025	Active
Leadartis Sodena Direct	Biotech	Spain	Sodena	2021	Active
Leal Therapeutics Dementia Discovery Fund 2	Biotech	United States	SV Health Managers	2025	Active
Lever Bio Claris Biotech I	Biotech	Italy	Claris Ventures SGR	2025	Active
Libra Therapeutics Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2020	Active
Lighthouse Biotech Utopia SIS	Biotech	Italy	Utopia SIS	2021	Active
Lipum Flerie Invest	Biotech	Sweden	Flerie	2021	Active
LogicBio BioDiscovery 5	Biotech	France	Andera Partners	2017	Active
Lutris Pharma Columbus Life Sciences Fund III	Biotech	Israel	Columbus Venture Partners	2025	Active
Macro Biologics Oscar & Paul Venture Capital Fund I	Biotech	United States	Oscar & Paul (Beiersdorf Venture Capital)	2024	Active
Mage Biologics, Inc. TVM Life Science Innovation	Biotech	United States	TVM Capital Life Science	2023	Active
Mahzi Therapeutics HealthCap VII	Biotech	United States	HealthCap	2020	Active
MapLight Therapeutics Novo Holdings Growth Investments	Biotech	United States	Novo Holdings	2023	Active
Mariposa Therapeutics Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2026	Active
MDTB Cell Manufacturing HTGF IV	Biotech	Germany	High-Tech Gruenderfonds (HTGF)	2023	Active
Mendus Flerie Invest	Biotech	Sweden	Flerie	2023	Active
MeOmics Precision Medicine Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2026	Active
Mesenkia Almi Invest (Regional funds)	Biotech	Sweden	Almi Invest	2025	Active
MoglingBio KIZOO Evergreen (Balance Sheet)	Biotech	Germany	KIZOO Technology Capital	2022	Active
Mogrify Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2021	Active
Moleculent Eir Ventures I	Biotech	Sweden	Eir Ventures	2024	Active
Montara Therapeutics Dementia Discovery Fund	Biotech	United States	SV Health Managers	2024	Active
Mucolife Therapeutics GU Ventures Evergreen	Biotech	Sweden	GU Ventures	2024	Active
Nanoligent Inveready Biotech III	Biotech	Spain	Inveready Asset Management	2025	Active
Nanologica Flerie Invest	Biotech	Sweden	Flerie	2014	Active
Navinci Diagnostics Segulah Medical Acceleration	Biotech	Sweden	Segulah Medical Acceleration	2022	Active
Neobiomics HealthCap VIII	Biotech	Sweden	HealthCap	2026	Active
NeoEarth First Imagine! Ventures	Biotech	France	First Imagine! Ventures	2025	Active
Neomatrix S.r.l. Deutsche Balaton Evergreen Holding (Balance Sheet)	Biotech	Italy	Deutsche Balaton Aktiengesellschaft	2023	Active
Neotis Daphni Blue	Biotech	France	Daphni	2025	Active
NetZeroNitrogen Revent Fund I	Biotech	United Kingdom	Revent	2023	Active
neuway Pharma Wellington Partners Life Sciences	Biotech	Germany	Wellington Partners	2014	Active
New Dawn Bio Norrsken Accelerator	Biotech	Netherlands	Norrsken Accelerator	2025	Active
Nido Biosciences Abingworth Bioventures 8	Biotech	US	Abingworth	2023	Active
Notify Therapeutics Lundbeckfonden BioCapital	Biotech	Denmark	Lundbeckfonden BioCapital	2021	Active
NovaSAID Rosetta Capital IV	Biotech	Sweden	Rosetta Capital	2013	Active
Novonesis Novo Holdings Principal Investments	Biotech	Denmark	Novo Holdings	2000	Active
Novos Unilever Ventures (Evergreen)	Biotech	United States	Unilever Ventures	2026	Active
Numab Therapeutics Novo Holdings Growth Investments	Biotech	Switzerland	Novo Holdings	2021	Active
Obsidian Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2024	Active
Ocellaris Pharma TVM Life Science Innovation	Biotech	Canada	TVM Capital Life Science	2019	Active
Ochre Bio Apollo Health Ventures Fund II	Biotech	United Kingdom	Apollo Health Ventures	2021	Active
OnCusp Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2024	Active
Opthea Abingworth Clinical Co-Development Fund 2	Biotech	Australia	Abingworth	2022	Active
Oriva Therapeutics Sabadell Asabys Health Innovation Investments II	Biotech	Spain	Asabys Partners	2026	Active
Oxford Cancer Analytics Eka Ventures Fund I	Biotech	UK	EKA Ventures	2022	Active
Oxolife Inveready Biotech III	Biotech	Spain	Inveready Asset Management	2020	Active
Pathalys Pharma Abingworth Bioventures 8	Biotech	US	Abingworth	2023	Active